peroxisome proliferator activated receptor [aapp, rcpt]
agonists [phsu]
Multimodality [diap]
Drugs [phsu]
treatment [ftcn]
Patients [podg]
considered [idcn]
To [qlco]
High Risk [qlco]
Cardiovascular disease [dsyn]
Last [qlco]
Decade [qnco]
peroxisome proliferator activated receptor [aapp, rcpt]
Subfamily [clas]
Receptors, Nuclear [aapp, rcpt]
Pharmacological [bmod]
Target [ftcn]
Activation [acty]
Normalize [resa]
Metabolic [ftcn]
dysfunction [ftcn]
cardiovascular risk factor [dsyn]
Associated [qlco]
Fibrates [orch, phsu]
Correct [qlco]
Dyslipidaemia [dsyn]
Thiazolidinediones [orch, phsu]
ACT [topp]
Insulin [aapp, horm, phsu]
Insulin Resistance [patf]
Patients [podg]
Restricted [ftcn]
Potential [qlco]
Certain [qlco]
side effects [ftcn]
peroxisome proliferator activated receptor [aapp, rcpt]
agonists [phsu]
Epidemic [phpr]
Incidence [qnco]
Real [qlco]
Need [qlco]
development [phsf]
peroxisome proliferator activated receptor [aapp, rcpt]
agonists [phsu]
Improved [qlco]
Clinical [qlco]
Efficacy [qlco]
This [euka]
chapter [idcn]
Focus [spco]
peroxisome proliferator activated receptor [aapp, rcpt]
agonists [phsu]
Currently [tmco]
Clinic [hcro, mnob]
Discovery [acty]
development [phsf]
Generation [tmco]
peroxisome proliferator activated receptor [aapp, rcpt]
agonists [phsu]
